Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A Little

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|August 25, 2019
Validation of a composite vascular high-risk profile for adult patients with sickle cell diseaseMehdi Nouraie, Jane A Little, Mariana Hildesheim, et al.
Biophysical Journal|May 13, 2023
Catch bonds in sickle cell disease: Shear-enhanced adhesion of red blood cells to lamininUtku Goreke, Shamreen Iram, Gundeep Singh, et al.
Journal of Pain Research|January 20, 2022
Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility StudySamuel N Rodgers-Melnick, Lucas Lin, Kristina Gam, et al.
Biosensors & Bioelectronics|December 15, 2022
A microfluidic device for assessment of E-selectin-mediated neutrophil recruitment to inflamed endothelium and prediction of therapeutic response in sickle cell diseaseYuncheng Man, Erdem Kucukal, Shichen Liu, et al.
Lab on a Chip|April 21, 2021
Emerging point-of-care technologies for anemia detectionRan An, Yuning Huang, Yuncheng Man, et al.
Blood|November 18, 2005
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseGregory J Kato, Vicki McGowan, Roberto F Machado, et al.
European Journal of Haematology|February 14, 2009
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapyJane A Little, Kristine Partovi Hauser, Sabrina E Martyr, et al.
British Journal of Haematology|April 30, 2020
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell diseasePanae Noomuna, Mary Risinger, Sitong Zhou, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacyMatthew S Karafin, Ross M Fasano, Anton Illich, et al.
Haematologica|August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewJane A Little, Vicki R McGowan, Gregory J Kato, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|August 25, 2019
Validation of a composite vascular high-risk profile for adult patients with sickle cell diseaseMehdi Nouraie, Jane A Little, Mariana Hildesheim, et al.
Biophysical Journal|May 13, 2023
Catch bonds in sickle cell disease: Shear-enhanced adhesion of red blood cells to lamininUtku Goreke, Shamreen Iram, Gundeep Singh, et al.
Journal of Pain Research|January 20, 2022
Effects of Music Therapy on Quality of Life in Adults with Sickle Cell Disease (MUSIQOLS): A Mixed Methods Feasibility StudySamuel N Rodgers-Melnick, Lucas Lin, Kristina Gam, et al.
Biosensors & Bioelectronics|December 15, 2022
A microfluidic device for assessment of E-selectin-mediated neutrophil recruitment to inflamed endothelium and prediction of therapeutic response in sickle cell diseaseYuncheng Man, Erdem Kucukal, Shichen Liu, et al.
Lab on a Chip|April 21, 2021
Emerging point-of-care technologies for anemia detectionRan An, Yuning Huang, Yuncheng Man, et al.
Blood|November 18, 2005
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseGregory J Kato, Vicki McGowan, Roberto F Machado, et al.
European Journal of Haematology|February 14, 2009
Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapyJane A Little, Kristine Partovi Hauser, Sabrina E Martyr, et al.
British Journal of Haematology|April 30, 2020
Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell diseasePanae Noomuna, Mary Risinger, Sitong Zhou, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacyMatthew S Karafin, Ross M Fasano, Anton Illich, et al.
Haematologica|August 4, 2006
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewJane A Little, Vicki R McGowan, Gregory J Kato, et al.
Pageof 7